Expression of vascular endothelial growth factor and microvessel density in oral squamous cell carcinoma and its correlation with various clinico-pathological parameters
DOI:
https://doi.org/10.15584/ejcem.2024.1.15Keywords:
microvessel density, oral squamous cell carcinoma, vascular endothelial growth factorAbstract
Introduction and aim. Angiogenesis, which is accomplished by capillary sprouting, is the process by which new vessels are created from pre-existing ones. In tumor, once their initial blood supply is depleted, a tumour is unable to grow without additional blood flow. Additionally, a tumor’s microvasculature, or microvessel density (MVD), increases along with its capacity to produce angiogenesis. We aimed to observe the relationship between the expression of vascular endothelial growth factor (VEGF) and MVD (using CD34) in oral squamous cell carcinoma (OSCC).
Material and methods. The expression of VEGF and CD34 antibodies was analysed using immunohistochemistry method on 50 cases of histopathologically proved OSCC. The expression was correlated with clinicopathological parameters.
Results. A significant correlation was observed between VEGF expression and gender, LVSI. No correlation between any other factors and the difference in VEGF expression was statistically significant. Similarly, the MVD expression was not found to be statistically significant in any of the pathological parameters.
Conclusion. VEGF positivity as well as MVD were found to be independent of the tumor pathology. Tumor MVD was found to be independent of the expression of VEGF. Further studies in a larger study group may establish a significant association so that antiangiogenic targeted therapy may be initiated.
Downloads
References
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7-30.doi: 10.3322/caac.21590
Misra S, Chaturvedi A, Misra NC. Management of gingivobuccal complex cancer. Ann R Coll Surg Engl. 2008;90:546-553. doi: 10.1308/003588408X301136
Dissanayaka WL, Pitiyage G, Kumarasiri PV, Liyanage RL, Dias KD, Tilakaratne WM. Clinical and histopathologic parameters in survival of oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113:518-525. doi: 10.1016/j.oooo.2011.11.001
Marocchio LS, Lima J, Sperandio FF, Corrêa L, de Sousa SO. Oral squamous cell carcinoma: an analysis of 1,564 cases showing advances in early detection. J Oral Sci. 2010;52(2):267-273. doi:10.2334/josnusd.52.267
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90. doi:10.3322/caac.20107
Noorlag R, van Kempen PM, Stegeman I, Koole R, van Es RJ, Willems SM. The diagnostic value of 11q13 amplification and protein expression in the detection of nodal metastasis from oral squamous cell carcinoma: a systematic review and meta-analysis. Virchows Arch. 2015;466(4):363-373. doi:10.1007/s00428-015-1719-6
Varma S, Shameena PM, Sivasankaran S, Kumar KPM, Varekar AA. Vascular Endothelial Growth Factor Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma. Oral Maxillofac Pathol J. 2014;5:423-428.doi: 10.5005/jp-journals-10037-1002
Cortesina G, Martone T. Molecular metastases markers in head and neck squamous cell carcinoma: review of the literature. Acta Otorhinolaryngol Ital. 2006;26(6):317-325.
Kerbel RS. Tumor angiogenesis: past, present and the near future. Carcinogenesis. 2000;21(3):505-515. doi:10.1093/carcin/21.3.505
Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature. 2000;407(6801):242-248. doi:10.1038/35025215
Soini Y, Puhakka A, Kahlos K, et al. Endothelial nitric oxide synthase is strongly expressed in malignant mesothelioma but does not associate with vascular density or the expression of VEGF, FLK1 or FLT1. Histopathology. 2001;39(2):179-186. doi:10.1046/j.1365-2559.2001.01211.x
Kukreja I, Kapoor P, Deshmukh R, Kulkarni V. VEGF and CD 34: A correlation between tumor angiogenesis and microvessel density-an immunohistochemical study. J Oral Maxillofac Pathol. 2013;17(3):367-373. doi:10.4103/0973-029X.125200
Maeda T, Matsumura S, Hiranuma H, et al. Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its association with tumour progression and p53 gene status. J Clin Pathol. 1998;51(10):771-775. doi:10.1136/jcp.51.10.771
Li S-H, Hung P-H, Chou K-C, Hsieh S-H, Shieh Y-S. Tumor Angiogenesis inOral Squamous Cell Carcinomas: The Significance of Endothelial Markersand Hotspot Selection. J Med Sci. 2009;29:067-074.10.6136/JMS.2009.29(2).067
Astekar M, Joshi A, Ramesh G, Metgud R. Expression of vascular endothelial growth factor and microvessel density in oral tumorigenesis. J Oral MaxillofacPathol. 2012;16(1):22-26. doi:10.4103/0973-029X.92968
Johnstone S, Logan RM. Expression of vascular endothelial growth factor (VEGF) in normal oral mucosa, oral dysplasia and oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2007;36(3):263-266. doi: 10.1016/j.ijom.2006.09.017
Sappayatosok K, Maneerat Y, Swasdison S, et al. Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation. Med Oral Patol Oral Cir Bucal. 2009;14(7):319-324.
Jalayer Naderi N, Tirgari F, Keshavarz Z. Vascular endothelial growth factor expression and vascular density in oral squamouscell carcinoma (OSCC): A study on clinical and histopathologic significance. Med J Islam Repub Iran.2016;30:358.
Shang ZJ, Li ZB, Li JR. VEGF is up-regulated by hypoxic stimulation and related to tumour angiogenesis and severity of disease in oral squamous cell carcinoma: in vitro and in vivo studies. Int J Oral Maxillofac Surg. 2006;35(6):533-538. doi:10.1016/j.ijom.2005.09.006
Tae K, El-Naggar AK, Yoo E, et al. Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis. Clin Cancer Res. 2000;6(7):2821-2828.
Ascani G, Balercia P, Messi M, et al. Angiogenesis in oral squamous cell carcinoma. Acta OtorhinolaryngolItal. 2005;25(1):13-17.
Shahsavari F, Farhadi S, Sadri D, Sedehi M. Evaluation of Microvascularity by CD34 Expression in Esophagus and Oral Squamous Cell Carcinoma. J Contemp Dent Pract. 2015;16(6):458-462. doi:10.5005/jp-journals-10024-1706
Maqsood A, Ali A, Zaffar Z, et al. Expression of CD34 and α-SMA Markers in Oral Squamous Cell Carcinoma Differentiation. A Histological and Histo-Chemical Study. Int J Environ Res Public Health. 2020;18(1):192. doi:10.3390/ijerph18010192
Mohammed A, Hassan A , Abdallah D. Elnagdy S-Y, Evaluation of mean vascular density (MVD) and cells adhesion in oral squamous cell carcinoma. An immunohistochemical study. Mansoura Journal of Dentistry.2021;8:21-28.doi:10.21608/MJD.2021.199969
Elmorsy A, Omar T, Fouad H, Fata M. Blood vessel density as a predictor in oral squamous cell carcinoma using CD34. Alexandria Dental Journal. 2019;44:46-51.doi:10.21608/ADJALEXU.2019.57362
Shieh YS, Lee HS, Shiah SG, Chu YW, Wu CW, Chang LC. Role of angiogenic and non-angiogenic mechanisms in oral squamous cell carcinoma: correlation with histologic differentiation and tumor progression. J Oral Pathol Med. 2004;33(10):601-606. doi:10.1111/j.1600-0714.2004. 00252.x
Artese L, Rubini C, Ferrero G, Fioroni M, Santinelli A, Piattelli A. Microvessel density (MVD) and vascular endothelial growth factor expression (VEGF) in human oral squamous cell carcinoma. Anticancer Res. 2001;21(1B):689-695.
Miyahara M, Tanuma J, Sugihara K, Semba I. Tumorlymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Cancer. 2007;110(6):1287-1294. doi:10.1002/cncr.22900
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
